Frequent inactivation of the tumor suppressor Kruppel-like factor 6 (KLF6) in hepatocellular carcinoma.
about
Mammalian Krüppel-like factors in health and diseasesTumor suppressor and hepatocellular carcinomaA novel KLF6-Rho GTPase axis regulates hepatocellular carcinoma cell migration and disseminationKLF6 induces apoptosis in prostate cancer cells through up-regulation of ATF3Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liverp21 in cancer: intricate networks and multiple activitiesGenetic and genomic analysis modeling of germline c-MYC overexpression and cancer susceptibilityTargeted reduction of KLF6-SV1 restores chemotherapy sensitivity in resistant lung adenocarcinoma.Loss of runt-related transcription factor 3 expression leads hepatocellular carcinoma cells to escape apoptosis.Platelet releasates promote the proliferation of hepatocellular carcinoma cells by suppressing the expression of KLF6KLF6 depletion promotes NF-κB signaling in glioblastoma.Aberrant expression of krUppel-like factor 6 protein in colorectal cancers.Frequent loss of heterozygosity in two distinct regions, 8p23.1 and 8p22, in hepatocellular carcinoma.Nucleo-cytoplasmic localization domains regulate Krüppel-like factor 6 (KLF6) protein stability and tumor suppressor functionIdentification of miRNAs that specifically target tumor suppressive KLF6-FL rather than oncogenic KLF6-SV1 isoform.Functional role of the KLF6 tumour suppressor gene in gastric cancer.Krüppel-like factor 4, a tumor suppressor in hepatocellular carcinoma cells reverts epithelial mesenchymal transition by suppressing slug expression.Emerging roles of Kruppel-like factor 6 and Kruppel-like factor 6 splice variant 1 in ovarian cancer progression and treatment.KLF6-SV1 overexpression accelerates human and mouse prostate cancer progression and metastasis.Inactivation of the tumor suppressor Krüppel-like factor 6 (KLF6) by mutation or decreased expression in hepatocellular carcinomas.Developmental regulation of yolk sac hematopoiesis by Kruppel-like factor 6Enhanced hepatocarcinogenesis in mouse models and human hepatocellular carcinoma by coordinate KLF6 depletion and increased messenger RNA splicing.Expression and significance of Kruppel-like factor 6 gene in osteosarcoma.KLF6-SV1 drives breast cancer metastasis and is associated with poor survivalReduced hepatic stellate cell expression of Kruppel-like factor 6 tumor suppressor isoforms amplifies fibrosis during acute and chronic rodent liver injury.Downregulation of KLF6 is an early event in hepatocarcinogenesis, and stimulates proliferation while reducing differentiation.Transcriptional regulation of stellate cell activation.The Pathobiology of Krüppel-like Factors in Colorectal Cancer.The tumor suppressor Kruppel-like factor 6 is a novel aryl hydrocarbon receptor DNA binding partner.Role of Kruppel-like factor 6 in transforming growth factor-beta1-induced epithelial-mesenchymal transition of proximal tubule cellsExpression and Function of Kruppel Like-Factors (KLF) in Carcinogenesis.Interaction of KLF6 and Sp1 regulates basigin-2 expression mediated proliferation, invasion and metastasis in hepatocellular carcinoma.GSK3β phosphorylation of the KLF6 tumor suppressor promotes its transactivation of p21.Acid ceramidase upregulation in prostate cancer: role in tumor development and implications for therapyKrüppel-like factors in hepatocellular carcinoma.The Role of the 3' Untranslated Region in the Post-Transcriptional Regulation of KLF6 Gene Expression in Hepatocellular CarcinomaSP and KLF Transcription Factors in Digestive Physiology and Diseases.Tumor suppressor activity of KLF6 mediated by downregulation of the PTTG1 oncogeneMicroRNA-181a promotes gastric cancer by negatively regulating tumor suppressor KLF6.A small interfering RNA targeting the KLF6 splice variant, KLF6-SV1, as gene therapy for gastric cancer.
P2860
Q24612560-7910F68E-962E-45F3-BE18-BB91A9DC295AQ28389231-E9C77BC5-1695-42CF-899B-E357BFB92407Q28597820-1D58EA79-A0CC-49E9-9B8C-D17CB710DBC7Q28771723-689FF19B-A5D4-4D70-8BB4-DB1B1466910AQ29616840-2DCC5C94-97AC-4030-B71D-93EB0B132C0AQ30436015-DE3ADA52-1BE2-4512-8D75-C4CFE37F76D3Q33314433-89EBBF61-A695-4322-AC35-9277D341F2A8Q33699499-963C245B-D6B9-4842-89B5-8C6F7F766D78Q33785451-08602569-C407-4502-873A-8DCD4C0A25EDQ33822598-7679A958-67B5-4263-8ACB-F84ECAB96798Q33835953-32E3C542-57D3-4509-B9C0-810E0F1E63F4Q33867171-3C029618-DE04-4C73-ADF3-769E99134C20Q34099045-64A02D6A-9DF9-4AF5-B80F-6381EA2129B5Q34115273-C453A64D-A73C-4106-80E1-6BD986CF953EQ34266462-E467DD3B-7BBB-4CE0-88CB-5677D4BAF72EQ34267693-06B066C0-119D-472A-8517-7BC62CC1140EQ34399237-DF7E16E9-CBDA-42D5-B357-9E94EC5B1D9FQ34698278-F7C9F0AB-D9F8-48AA-94C4-2336AF6416B8Q34791651-150E9CD9-55FB-45DD-AB64-B9FAE580C800Q35080180-BD92D3AB-2CE2-47BB-B5A5-260F69730925Q35848611-679AEA3B-5A3C-43F5-8AF8-23F4683C2544Q36141301-54601753-CCFC-4E96-B33F-464783E4FF59Q36285123-09465904-39C5-4AB2-B9B3-7ED59694E215Q36324431-0656409A-0149-4157-B214-14BEE584208AQ36467939-730F9A26-B923-4645-BFBC-EF361A3E5E77Q36497062-002DB8FF-FE91-4C5D-B814-A01163C44757Q36588242-254A8941-9094-43F3-835B-8FBF7FD6D20FQ36672289-19538F8A-A6E4-40B2-92BD-848E401F52E8Q36852614-E4C25AA4-EFD3-4760-970F-DA9FBA8CB93AQ36977366-9EAA4A31-9C24-48CA-8ECA-D6447D2A3110Q37313427-E0F7970C-4BE7-4419-8C42-3E1C22E1C91AQ37317457-090F812D-8ED8-4BF1-9FFC-5D3F886E4731Q37483185-2C87D73E-259D-493D-90D8-807DD99BACC6Q37486242-8FA7211C-DE8F-4A1F-95C6-A54D37CA8957Q38344470-FA4D6192-538F-4134-B072-B322AB279C52Q38671852-607DE141-FF8B-4871-A9E9-426D889AA34DQ39214035-0CCD5D4D-F326-411D-9373-BA865691982DQ39238983-3A311C8C-363B-4CDB-AE76-418E7113AB6BQ39348967-B23995CD-6EEA-4A37-9EF1-73B7FCCC5B4CQ39549419-FA5F4B47-BB93-4F6A-9C6E-E29D059ACD75
P2860
Frequent inactivation of the tumor suppressor Kruppel-like factor 6 (KLF6) in hepatocellular carcinoma.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Frequent inactivation of the t ...... ) in hepatocellular carcinoma.
@en
type
label
Frequent inactivation of the t ...... ) in hepatocellular carcinoma.
@en
prefLabel
Frequent inactivation of the t ...... ) in hepatocellular carcinoma.
@en
P2093
P356
P1433
P1476
Frequent inactivation of the t ...... ) in hepatocellular carcinoma.
@en
P2093
Amanda Katz
Analisa Difeo
Goutham Narla
Helen L Reeves
John A Martignetti
Myron Schwartz
Scott L Friedman
Sigal Kremer-Tal
Swan N Thung
P304
P356
10.1002/HEP.20460
P407
P577
2004-11-01T00:00:00Z